OrphanReachLogo_1000x500_RGBOrphanReachLogo_1000x500_RGBOrphanReachLogo_1000x500_RGBOrphanReachLogo_1000x500_RGB
  • HOME
  • ABOUT
    • Note from the CEO
    • History
    • Orphan Reach-Emmes Merger
    • Our Clients
    • Quality
    • Why Orphan Reach
  • SERVICES
    • Orphan Strategy
    • Natural History
    • Clinical Development
      • Project Management
      • Clinical Monitoring
      • Regulatory Affairs
      • Data Management & Biostatistics
      • Safety/Pharmacovigilance
      • Quality Assurance
      • Investigator Recruitment
    • COA Training
    • Patient Support
    • Registries
  • ORPHAN FOCUS
    • Clinical Development Delivery
    • Orphan Strategy
    • Patient Recruitment
    • Patient Retention
    • Pediatric Research
  • GLOBAL REACH
    • North America
    • South America
    • Europe
    • Russia, Ukraine & Baltic Countries
    • Asia Pacific
    • India
    • Middle East
    • Africa
  • COVID-19
  • CONTACT
    • CAREERS
  • RESOURCES
    • Rare Disease Center Insights
    • White Papers
    • Latest News
    • Charity Spotlight Series
✕

Rare Disease

  • Home
  • New Releases
  • Rare Disease
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Covid 19
  • Events
  • News
  • Orphan Drug Development
  • Orphan Drug Research
  • Orphan Drug Trials
  • Orphan Drugs
  • orphan reach
  • Outsourcing in Clinical Trials
  • Rare Disease
  • Rare disease community
  • Rare Disease Day
  • Uncategorized
  • All
  • #Best CRO
  • #orphan drugs
  • Award winning CRO
  • clinical research
  • clinical trials
  • Clinical Trials in UK
  • clinical trials in US
  • Corona virus
  • Corona virus research
  • Covid-19
  • COVID-19 research
  • CRO in Europe
  • CRO in India
  • CRO in USA
  • orphan drug research
  • orphan drugs
  • orphan reach
  • patient centric
  • rare disease
  • rare disease research
  • rare disease US
  • Special CRO
  • Vicore Pharma
  • All
  • skhawas@qed-clinical.com
  • Georgia Rose
  • Thomas
October 18, 2019

Orphan Reach to attend Outsourcing in Clinical Trials Nordics 2019 in Copenhagen

We are pleased to confirm that Orphan Reach will be attending Outsourcing in Clinical Trials Nordics next week. Meet our Client Relationship Manager, who will be […]
Do you like it?3
Read more
October 31, 2019

Orphan Reach to attend World Orphan Drug Congress in Barcelona

We are delighted to be exhibiting at World Orphan Drug Congress, Barcelona in less than two weeks’ time. The conference agenda covers the strategic and commercial […]
Do you like it?2
Read more
May 17, 2021

Orphan Reach confirms acquisition by Emmes, a US-based global, full-service CRO

Orphan Reach today confirmed that they have been acquired by Emmes, a global, full-service CRO dedicated to supporting the advancement of public health and biopharmaceutical innovation. […]
Do you like it?12
Read more
August 20, 2021

Emmes is excited to be attending the World Orphan Drug Congress in the USA

Emmes is excited to be attending the World Orphan Drug Congress USA 2021, from August 25th – 27th in Oxon Hill, MD USA The World Orphan […]
Do you like it?12
Read more
Prev page
123
Next page

Clinical Development Services

  • Project Management
  • Clinical Monitoring
  • Regulatory Affairs
  • Data Management & Biostatistics
  • Safety/Pharmacovigilance
  • Investigator Recruitment
  • Quality Assurance

RSS Industry News

Latest News

  • Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research November 16, 2021
  • Emmes launches Orphan Reach™: Emmes’ Rare Disease Center November 3, 2021
  • Emmes is excited to be attending the World Orphan Drug Congress in the USA August 20, 2021
  • Orphan Reach confirms acquisition by Emmes, a US-based global, full-service CRO May 17, 2021

Quick Links

  • Emmes’ External Privacy Notice
  • Terms of Use
  • Privacy and Cookie Policy
  • Emmes – About us
  • CheckOrphan
  • European Medicines Agency
  • EURORDIS
  • Global Rare Diseases Patient Registry and Data Repository (GRDR)
  • NIH – Common Data Elements
  • NORD
  • Rare Disease UK
  • U.S. Food and Drug Administration
  • Sitemap

Headquarters

The Old School
Newport Road
Woughton Park
Milton Keynes MK6 3AP
United Kingdom
Phone: +44 (0)1908 251 480
Fax: +44 (0)1908 251 499
E-mail: info@orphan-reach.com

Global office locations

Follow Us





© 2022 Orphan Reach™- A Rare Disease CRO for Orphan Drugs. All Rights Reserved.

    Input this code: captcha


    There are some changes in the data protection law, so we wanted you to know that we've updated our Privacy Policy. Your trust is important to us, and we want to make sure you understand what these changes mean for you.

    Please visit our Privacy Policy page for more information about our Privacy and Cookie Policy.

    Close